Skip to main content
. 2023 Sep 18;38(9):880–901. doi: 10.1080/02699206.2023.2254458

Figure 2.

Figure 2.

Measures of speech rate for healthy control participants (HC), people with mild cognitive impairment (PwMCI), people with Alzheimer’s disease (PwAD) and people with diagnosed early stage neurodegenerative disorders (PwND; PwMCI + PwAD).